ACE Incubator
ACE Incubator is a university startup incubator based in Amsterdam, jointly owned by four academic institutions: the University of Amsterdam, Vrije Universiteit, Hogeschool van Amsterdam, and Amsterdam UMC. It is dedicated to supporting researchers, scientists, students, and entrepreneurs with technology-driven ideas, helping them transform their concepts into viable businesses. The incubator hosts young entrepreneurs who are developing innovative solutions in sectors such as deep tech, medical and health technology, chemical and advanced materials, and sustainable technology. ACE provides a range of resources, including tailored programs, startup facilities, an extensive entrepreneurial network, and mentorship from experienced startup professionals, thereby facilitating the growth of ambitious science and high-tech entrepreneurs at all stages of their business journey.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Amsterdam
Dyme
Pre Seed Round in 2018
Dyme is a personal finance platform that consolidates all subscriptions in one place, enabling users to manage, cancel, and switch services from a single app. It uses financial data and machine learning to provide a clear overview of income and expenses, offer insights into spending, and assist with renegotiating contracts to help users reduce fixed costs.
Aiir Innovations
Pre Seed Round in 2016
Founded in 2016, Aiir Innovations specializes in developing software solutions that optimize industrial processes using artificial intelligence and computer vision. Its flagship product automates borescope inspection analysis for aircraft engines, enhancing efficiency, accuracy, and safety during maintenance.
Hep-Art Medical Devices
Pre Seed Round in 2015
Hep-Art Medical Devices B.V. is a spin-off from the Academic Medical Center in Amsterdam, focused on developing innovative solutions for patients suffering from acute liver failure (ALF). The company's flagship product, the AMC-BAL, is a bio-artificial liver system designed to support liver function during critical periods, either facilitating recovery or bridging the time until a donor liver becomes available. This extracorporeal device operates through a bioreactor that contains embedded liver cells, specifically porcine hepatocytes, which effectively treat the patient's plasma and temporarily replace essential liver functions. Initial clinical trials have demonstrated the safety of the AMC-BAL, marking a significant advancement in the management of acute liver conditions.
NICO.LAB
Pre Seed Round in 2014
Born from the MRCLEAN trial, NICO.LAB was founded in 2015 as a spin-off from the Amsterdam University Medical Center. Our research background continues to drive our way of thinking. The team consists of researchers, developers and experienced medical specialists to ensure we align with our clients needs. We believe connecting human & artificial intelligence will revolutionize emergency care.
Our cloud-based solution, StrokeViewer, automatically analyses brain CT scans and gives results within minutes. StrokeViewer empowers physicians in the emergency setting to provide patients with the right treatment in time.
InCatT
Pre Seed Round in 2014
InCatT specializes in contract research for catalyst development, serving various industries such as pharmaceuticals, flavors & fragrances, oil & gas, and fine chemicals. The company offers services including high-throughput screening, catalyst optimization, and scale-up studies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.